12,364 Shares in HCP, Inc. (HCP) Acquired by Comerica Securities Inc.

Comerica Securities Inc. purchased a new stake in HCP, Inc. (NYSE:HCP) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 12,364 shares of the real estate investment trust’s stock, valued at approximately $345,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Private Ocean LLC lifted its position in shares of HCP by 251.7% during the 4th quarter. Private Ocean LLC now owns 1,674 shares of the real estate investment trust’s stock valued at $47,000 after acquiring an additional 1,198 shares during the period. Nvwm LLC bought a new stake in shares of HCP during the 4th quarter valued at $48,000. Capital Investment Advisory Services LLC bought a new stake in shares of HCP during the 4th quarter valued at $102,000. CWM LLC lifted its position in shares of HCP by 9.2% during the 4th quarter. CWM LLC now owns 4,064 shares of the real estate investment trust’s stock valued at $114,000 after acquiring an additional 341 shares during the period. Finally, Private Capital Group LLC lifted its position in shares of HCP by 71.4% during the 4th quarter. Private Capital Group LLC now owns 4,286 shares of the real estate investment trust’s stock valued at $120,000 after acquiring an additional 1,786 shares during the period. Institutional investors and hedge funds own 88.78% of the company’s stock.

Shares of HCP stock opened at $30.75 on Thursday. The company has a quick ratio of 0.48, a current ratio of 0.48 and a debt-to-equity ratio of 1.21. HCP, Inc. has a twelve month low of $21.48 and a twelve month high of $31.65. The firm has a market cap of $14.85 billion, a P/E ratio of 15.77, a price-to-earnings-growth ratio of 13.87 and a beta of 0.46.

HCP (NYSE:HCP) last announced its quarterly earnings data on Wednesday, February 13th. The real estate investment trust reported $0.43 earnings per share for the quarter, hitting the consensus estimate of $0.43. HCP had a return on equity of 3.06% and a net margin of 9.16%. The business had revenue of $441.92 million during the quarter, compared to the consensus estimate of $445.81 million. During the same period in the prior year, the company earned $0.48 EPS. HCP’s revenue for the quarter was down .3% on a year-over-year basis. On average, research analysts expect that HCP, Inc. will post 1.82 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, February 28th. Investors of record on Tuesday, February 19th will be given a dividend of $0.37 per share. The ex-dividend date is Friday, February 15th. This represents a $1.48 annualized dividend and a dividend yield of 4.81%. HCP’s dividend payout ratio is currently 75.90%.

In related news, COO Thomas Klaritch sold 82,532 shares of the company’s stock in a transaction on Tuesday, December 4th. The stock was sold at an average price of $29.51, for a total transaction of $2,435,519.32. Following the completion of the sale, the chief operating officer now directly owns 256,280 shares in the company, valued at approximately $7,562,822.80. The sale was disclosed in a filing with the SEC, which is available through this link. 0.14% of the stock is owned by corporate insiders.

A number of analysts have recently weighed in on HCP shares. Robert W. Baird upgraded HCP from a “neutral” rating to an “outperform” rating in a research report on Monday, January 7th. Royal Bank of Canada upgraded HCP from a “sector perform” rating to an “outperform” rating in a research report on Friday, November 2nd. ValuEngine upgraded HCP from a “hold” rating to a “buy” rating in a research report on Monday, November 12th. BMO Capital Markets upgraded HCP from a “market perform” rating to an “outperform” rating and upped their target price for the company from $30.00 to $33.00 in a research report on Wednesday, January 9th. Finally, Scotiabank started coverage on HCP in a research report on Monday, December 10th. They set an “outperform” rating and a $32.00 target price for the company. Three analysts have rated the stock with a sell rating, five have given a hold rating and nine have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $27.50.

ILLEGAL ACTIVITY NOTICE: “12,364 Shares in HCP, Inc. (HCP) Acquired by Comerica Securities Inc.” was first reported by Stock Observer and is owned by of Stock Observer. If you are reading this story on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark law. The correct version of this story can be read at https://www.thestockobserver.com/2019/02/14/12364-shares-in-hcp-inc-hcp-acquired-by-comerica-securities-inc.html.

HCP Profile

HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.

Featured Story: Average Daily Trade Volume – What It Means In Stock Trading

Institutional Ownership by Quarter for HCP (NYSE:HCP)

Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply